Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%
Market cap
$9.7B
P/E
25.0×
Fwd P/E
18.5×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Net Income

+8 more TTM periods

412.00 419.00 418.00 426.00
Operating Cash Flow
535.00 712.00 578.00 700.00
Investing cash flow
(311.00) (400.00) (364.00) (331.00)
Financing cash flow
(186.00) (188.00) (157.00) (381.00)
Ending Cash
132.00 156.00 167.00 168.00

Show all line items

In millions of $ except per-share values · columns are period end dates